• January 28, 2021

Govt, Health News, ET HealthWorld

Sep 16, 2020

New Delhi: As of Tuesday, there are 62,979 ICU beds and 32,862 ventilators available in Covid -19 dedicated government and private health facilities across the country as per data shared by states, the health ministry told Parliament.

Maharashtra tops the list with 14,447 ICU beds and 6866 ventilators in Covid-dedicated hospitals, followed by Tamil Nadu which has 8439 ICU beds and 4256 ventilators. Karnataka has reported availability of 5064 ICU beds and 3398 ventilators. The national capital has 2213 ICU beds and 1363 ventilators. Among the large states, Uttar Pradesh has 4256 ICU beds and 2343 ventilators, West Bengal 1284 ICU beds and 823 ventilators and Bihar 640 ICU beds and 788 ventilators.

Sharing the state-wise information in response to a written question in Rajya Sabha, minister of state for health Ashwini Kumar Choubey said the data is based on information provided by states/UTs on the Covid-19 portal. On whether the government has taken steps to augment the number of ventilators in government hospitals in view of surging cases of coronavirus, Choubey said so far, 32,109 ventilators have been allocated to various states and a total of 20,916 ventilators have been installed at the facilities.
He also said all states and UTs will be benefited as the ventilators are being allocated to states based on the number of cases, the trend of the pandemic and the requirement there. Maharashtra which has been reporting the maximum cases has been allocated the maximum number of ventilators (4434) among all states and of these 3131 are installed. In Delhi, 575 ventilators have been allocated and 508 installed. As many as 2894 ventilators have been allocated to central institutions.

On the quantum of fund released from PM CARES fund for this purpose, the minister said Rs 898.93 crore have been released from the Fund towards provision of ventilators.

On the status of Corona vaccine, the minister said, “While the government and industry are trying their best to make available a safe and effective vaccine for Covid-19 at the earliest, it is difficult to comment on the exact timelines in view of various complex pathways involved in vaccine development.”

Source link